Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences Inc (NQ: ENSC )

2.320 -0.050 (-2.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,495
Open 2.340
Bid (Size) 2.390 (33)
Ask (Size) 2.700 (11)
Prev. Close 2.370
Today's Range 2.310 - 2.400
52wk Range 2.290 - 220.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  On Friday, 63 companies hit new 52-week lows. 
Via Benzinga
Ensysce Biosciences Reports First Quarter 2023 Financial Results
Via ACCESSWIRE

Performance

YTD
-75.83%
-75.83%
1 Month
-36.96%
-36.96%
3 Month
-59.72%
-59.72%
6 Month
-93.40%
-93.40%
1 Year
-98.28%
-98.28%

More News

Read More
Ensysce Biosciences, Inc. Announces Closing of $7 Million Public Offering
Via ACCESSWIRE
Why Is Ensysce Biosciences (ENSC) Stock Up 50% Today?
Via InvestorPlace
Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Ensysce Biosciences (NASDAQ: ENSC) Successfully Completes Overdose-Protection Study
Via Spotlight Growth
Exposures Product Safety
Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development
Via ACCESSWIRE
Ensysce Biosciences Announces Updated Investor Presentation Available Via Investor Relations Website
Via ACCESSWIRE
Ensysce Biosciences's Return On Capital Employed Overview
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Are Ensysce Biosciences Shares Are Trading Higher Today
Via Benzinga
Ensysce Biosciences Announces Positive Results from Oral Human Abuse Potential Trial for PF614
Via ACCESSWIRE
Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
Via ACCESSWIRE
Ensysce Biosciences Announces Completion of Enrollment for Groundbreaking Opioid Overdose Protection Study
Via ACCESSWIRE
Dr. Lynn Kirkpatrick, Featured Speaker to Discuss Ensysce Overdose Protection Platform at DCAT Seminar
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday
Via Benzinga
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Ensysce Biosciences And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
ObsEva, Ensysce Biosciences And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.